Myopic choroidal neovascularization (mCNV)
Showing 1 - 25 of 835
Learn More About How Drug Aflibercept Works in Canadian Reduced
Active, not recruiting
- Myopic Choroidal Neovascularization
- Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
-
Multiple Locations, CanadaMany Locations
Jul 25, 2022
Use of Aflibercept Injections Into Eye for Treatment of Eye
Recruiting
- Retinal Disease
- Aflibercept (BAY86-5321, Eylea)
-
Multiple Locations, MexicoMany locations
Aug 22, 2022
Real Life Study in Myopic Neovascularization
Active, not recruiting
- Myopic Choroidal Neovascularisation
- AFLIBERCEPT
-
Poitiers, FranceChu de Poitiers
Sep 28, 2021
Myopic Choroidal Neovascularisation Trial in Beijing (CM082)
Suspended
- Myopic Choroidal Neovascularisation
-
Beijing, ChinaPeking Union Medical College Hospital
Mar 7, 2021
Diabetic Macular Edema, Age-Related Macular Degeneration, Choroidal Neovascularization Trial in Banha (Anti-vascular endothelial
Recruiting
- Diabetic Macular Edema
- +4 more
- Anti-vascular endothelial growth factors (Anti-VEGFs)
-
Banhā, Benha, EgyptAhmed Abdelshafy Tabl
Aug 8, 2022
Macular Degeneration, Age Related, Myopic Choroidal Neovascularisation, Proliferative Diabetic Retinopathy Trial in Perugia
Not yet recruiting
- Macular Degeneration, Age Related
- +4 more
- VISUPRIME
- Placebo
-
Perugia, PG, ItalyOspedale Santa Maria della Misericordia
Dec 22, 2022
Pathological Myopic Choroidal Neovascularization Trial in BeiJing (601, Ranibizumab)
Recruiting
- Pathological Myopic Choroidal Neovascularization
-
BeiJing, ChinaPeking Union Medical College Hospital
Jun 4, 2021
Quantitative Metamorphopsia- Measurements in Patients With mCNV
Completed
- Metamorphopsia
- App
-
Binningen, Baselland, SwitzerlandVista Klinik
Dec 8, 2021
Central Retinal Vein Occlusion With Macular Edema Trial in Tanta (Ziv-Aflibercept 25 MG/ML [Zaltrap])
Completed
- Central Retinal Vein Occlusion With Macular Edema
- Ziv-Aflibercept 25 MG/ML [Zaltrap]
-
Tanta, El Gharbia, EgyptTanta University
Oct 4, 2021
PIC and Its Role in Progression of Pathological Myopia
Unknown status
- Punctate Inner Choroidopathy
-
Tokyo, JapanTokyo Medical and Dental University
Jun 15, 2021
Induced Defocus to the Retina Trial in Houston (Plus powered optical lens)
Completed
- Induced Defocus to the Retina
- Plus powered optical lens
-
Houston, TexasUniversity of Houston College of Optometry
Mar 15, 2022
EYLEA for Myopic Choroidal Neovascularization
Completed
- Choroidal Neovascularization
- Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)
-
Multiple Locations, Japan(unnamed)
Sep 18, 2019
High Myopia: Extended and Longterm Observation of Pathologic
Completed
- Pathologic Myopia
- Observation & Diagnosis
-
Regensburg, Bavaria, Germany
- +25 more
Jul 18, 2019
Myopia Trial in Vejle (Orthokeratology lenses)
Completed
- Myopia
- Orthokeratology lenses
-
Vejle, Jylland, DenmarkVejle Hospital
Mar 3, 2022
Pathologic Myopia Trial in Mykolaiv, Odessa (Intravitreal injection)
Completed
- Pathologic Myopia
- Intravitreal injection
-
Mykolaiv, Ukraine
- +2 more
Jan 23, 2023
Neovascular Age-Related Macular Degeneration Trial in China (Brolucizumab 6mg, Aflibercept 2 mg)
Recruiting
- Neovascular Age-Related Macular Degeneration
- Brolucizumab 6mg
- Aflibercept 2 mg
-
Guangzhou, Guangdong, China
- +30 more
Jan 20, 2023
Optical Coherence Tomography Angiography and Choroidal Osteoma
Completed
- Choroidal Osteoma, Bilateral
- Optical coherence tomography angiography
-
Naples, Napoli, ItalyFederico II University
Apr 16, 2022
Neovascular Age-related Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion Trial in Shanghai (BD311)
Recruiting
- Neovascular Age-related Macular Degeneration
- +2 more
- BD311
-
Shanghai, Shanghai, ChinaEye & ENT Hospital of Fudan University
Aug 22, 2022
OCTA Insights in CNVM, Morphological Characteristics and
Not yet recruiting
- Choroidal Neovascularization
- (no location specified)
Sep 14, 2021
Pathologic Myopia Trial in Lutsk, Mykolaiv, Odesa (Intravitreal injection)
Recruiting
- Pathologic Myopia
- Intravitreal injection
-
Lutsk, Ukraine
- +3 more
Mar 23, 2022
Age-Related Macular Degeneration, Choroidal Neovascularization, Genetic Counseling Trial in Salt Lake City (Early disclosure,
Completed
- Age-Related Macular Degeneration
- +2 more
- Early disclosure
- Late disclosure
-
Salt Lake City, UtahUniversity of Utah John A. Moran Eye Center
Aug 10, 2022
Branch Retinal Vein Occlusion Trial in Damietta (aflibercept (2mg/0.05ml))
Completed
- Branch Retinal Vein Occlusion
- aflibercept (2mg/0.05ml)
-
Damietta, EgyptAkram Fekry Elgazzar
Nov 22, 2023
Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV
Recruiting
- Polypoidal Choroidal Vasculopathy
- +2 more
- Intravitreal aflibercept injection
-
Seoul, Korea, Republic ofJae Hui Kim
Dec 20, 2022
Myopia, Progressive Trial in Shanghai (Airdoc Red Lighting Device, Special Spectacles to Control Myopia)
Recruiting
- Myopia, Progressive
- Airdoc Red Lighting Device
- Special Spectacles to Control Myopia
-
Shanghai, ChinaShanghai Children Medical Center
May 21, 2023